Sphingomyelinases and Niemann-Pick disease
- PMID: 3009683
Sphingomyelinases and Niemann-Pick disease
Abstract
In the first part the properties of normal mammalian sphingomyelinases are reviewed: The lysosomal acid sphingomyelinase is a polymeric glycoprotein (subunit Mr between 28 000 and 70 000) which hydrolyses natural sphingomyelin, coloured and fluorescent semi-synthetic analogues (trinitrophenyl-aminolauryl-sphingomyelin and pyrenedecanoyl-sphingomyelin) and the synthetic analogue 2-N-hexadecanoylamido-nitrophenyl-phosphorylcholine. The suitability of these substrates and of synthetic fluorescent derivatives of methylumbelliferone is discussed. The effect of lipids, detergents and other effectors on the enzyme activity is also described. The neutral sphingomyelinase from brain tissue, localized in cell membranes, has a high Mr (160 000 and 600 000), is heat labile, hydrolyses sphingomyelin and its coloured and fluorescent analogues, but not 2-N-hexadecanoylamido-nitrophenyl-phosphorylcholine. A new method is available for determining enzyme activity in the intact cell through the utilization of endogenous or exogenous sphingomyelin as substrate. In the second part of the review, the classification of Niemann-Pick disease, the characteristic features of each type and the biological tools used for the diagnosis are reported. Experimental models (animal models and cellular models in culture) are reviewed with a particular attention to a new model system, Epstein-Barr virus-transformed lymphoid cell lines.
Similar articles
-
New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.Pediatr Res. 1985 Jan;19(1):153-7. doi: 10.1203/00006450-198501000-00039. Pediatr Res. 1985. PMID: 2982124
-
Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.Biochim Biophys Acta. 1984 Apr 18;793(2):321-4. doi: 10.1016/0005-2760(84)90337-0. Biochim Biophys Acta. 1984. PMID: 6324871
-
Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.Clin Chim Acta. 1988 Sep 15;176(3):259-67. doi: 10.1016/0009-8981(88)90185-4. Clin Chim Acta. 1988. PMID: 2846208
-
Brain sphingomyelinases.Adv Prostaglandin Thromboxane Res. 1978;3:1-10. Adv Prostaglandin Thromboxane Res. 1978. PMID: 26190 Review. No abstract available.
-
Prenatal diagnosis of Niemann-Pick diseases types A, B and C.Prenat Diagn. 2002 Jul;22(7):630-2. doi: 10.1002/pd.368. Prenat Diagn. 2002. PMID: 12124701 Review.
Cited by
-
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts.EMBO J. 1989 Sep;8(9):2469-73. doi: 10.1002/j.1460-2075.1989.tb08382.x. EMBO J. 1989. PMID: 2555181 Free PMC article.
-
Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):341-5. doi: 10.1042/bj3030341. Biochem J. 1994. PMID: 7980390 Free PMC article.
-
Ceramides are fuel gauges on the drive to cardiometabolic disease.Physiol Rev. 2024 Jul 1;104(3):1061-1119. doi: 10.1152/physrev.00008.2023. Epub 2024 Feb 1. Physiol Rev. 2024. PMID: 38300524 Free PMC article. Review.
-
Involvement of FAN in TNF-induced apoptosis.J Clin Invest. 2001 Jul;108(1):143-51. doi: 10.1172/JCI11498. J Clin Invest. 2001. PMID: 11435466 Free PMC article.
-
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling.Biochem J. 2001 May 1;355(Pt 3):859-68. doi: 10.1042/bj3550859. Biochem J. 2001. PMID: 11311151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical